How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish study.
Marilina SanteroCarolina RequeijoMaria Jesus QuintanaDulce RodríguezDavid BottaroIsmael MaciasCarles PericayNatalie FarinaJesus Manuel BlancoIratxe Urreta-BarallobreLaura PuntiMaria Angeles NavaXavier Bonfill CospPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
A high proportion of advanced EC patients receive many treatments not based on sound evidence and they do not benefit enough from palliative care services. The most accepted appropriateness indicators point out that some of the analyzed patients could have been overtreated. This study provides important insights into the quality of care provided to advanced EC, and furthermore, for giving valuable insight and opportunities for improvement.